Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Tazverik
.
Show all posts
Showing posts with label
Tazverik
.
Show all posts
Thursday, April 23, 2020
FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma
›
Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, announced that the U.S. Food...
›
Home
View web version
